On the 11th anniversary of World Orphan Drug Congress USA, Terrapin is building the most comprehensive program and inclusive gathering of rare disease stakeholders ever!

Becoming the largest rare disease and orphan drug conference, globally, has allowed them to bring together leading industry, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers. The attendees rely on the World Orphan Drug Congress USA to meet, brainstorm and dialogue on ways to advance orphan drug development and improve access to life-saving therapies.

Over 1,200 attendees will gather in Oxon Hill, Maryland on August 25th – 27th for the 11th edition of World Orphan Drug Congress USA!

This conference has become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing and commercialization of cell and gene therapies, as well the annual gathering for artificial intelligence and digital health solutions transforming the rare disease industry!